相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005
Jay D. Raman et al.
BJU INTERNATIONAL (2011)
Phase-II trial of combination treatment of interferon-alpha, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma
Manabu Tatokoro et al.
CANCER SCIENCE (2011)
Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis
Maxine Sun et al.
EUROPEAN UROLOGY (2011)
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation
Mieke Van Hemelrijck et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
High-Sensitivity C-Reactive Protein and Cancer
Seounghee Lee et al.
JOURNAL OF EPIDEMIOLOGY (2011)
Intratumor C-Reactive Protein as a Biomarker of Prognosis in Localized Renal Cell Carcinoma
T. V. Johnson et al.
JOURNAL OF UROLOGY (2011)
An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
Barbara Bottazzi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein
S. P. K. Jagdev et al.
BRITISH JOURNAL OF CANCER (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
T. Wethal et al.
EUROPEAN JOURNAL OF CANCER (2010)
Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients
Sei Naito et al.
EUROPEAN UROLOGY (2010)
Role of C-reactive protein as a biomarker for renal cell carcinoma
Kazutaka Saito et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
Campbell S. D. Roxburgh et al.
FUTURE ONCOLOGY (2010)
Absolute Preoperative C-Reactive Protein Predicts Metastasis and Mortality in the First Year Following Potentially Curative Nephrectomy for Clear Cell Renal Cell Carcinoma
T. V. Johnson et al.
JOURNAL OF UROLOGY (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Systemic Inflammatory Response and Survival in Patients with Localised Prostate Cancer: 10-Year Follow-Up
Peter A. McArdle et al.
UROLOGIA INTERNATIONALIS (2010)
Recent Time Trends in the Epidemiology of Stage IV Prostate Cancer in the United States: Analysis of Data From the Surveillance, Epidemiology, and End Results Program
Karynsa Cetin et al.
UROLOGY (2010)
Postoperative Better Than Preoperative C-reactive Protein at Predicting Outcome After Potentially Curative Nephrectomy for Renal Cell Carcinoma
T. V. Johnson et al.
UROLOGY (2010)
Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
Ingrid J. Orre et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma
Kazutaka Saito et al.
EUROPEAN UROLOGY (2009)
Multicenter Phase II Trial of Combination Therapy with Meloxicam, a COX-2 Inhibitor, and Natural Interferon-α for Metastatic Renal Cell Carcinoma
Nobuo Shinohara et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Development and External Validation of a New Outcome Prediction Model for Patients With Clear Cell Renal Cell Carcinoma Treated With Nephrectomy Based on Preoperative Serum C-Reactive Protein and TNM Classification: The TNM-C Score
Yasumasa Iimura et al.
JOURNAL OF UROLOGY (2009)
Clinical outcome of combined immunotherapy with interferon-α and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma
Hideaki Miyake et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy
Soichiro Yoshida et al.
BJU INTERNATIONAL (2008)
Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer
Sara Ramsey et al.
BJU INTERNATIONAL (2008)
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer
Tomasz M. Beer et al.
CANCER (2008)
Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy
Manabu Tatokoro et al.
JOURNAL OF UROLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
Donald C. McMillan
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Simple stratification of survival using bone scan and serum C-reactive protein in prostate cancer patients with metastases
Jun Nakashima et al.
UROLOGIA INTERNATIONALIS (2008)
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality - A European study of 313 patients
Pierre I. Karakiewicz et al.
CANCER (2007)
The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically
Kazutaka Saito et al.
BJU INTERNATIONAL (2007)
Grading systems in renal cell carcinoma
Giacomo Novara et al.
JOURNAL OF UROLOGY (2007)
Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer
Sara Ramsey et al.
CANCER (2007)
Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma
Yoshinobu Komai et al.
BJU INTERNATIONAL (2007)
Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma
Keiichi Ito et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Extremely elevated C-reactive protein
Steven Vanderschueren et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
U. M. Vogl et al.
BRITISH JOURNAL OF CANCER (2006)
The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer
GWA Lamb et al.
BRITISH JOURNAL OF CANCER (2006)
Systemic inflammatory response, prostate-specific antigen and survival in patients with metastatic prostate cancer
Peter A. McArdle et al.
UROLOGIA INTERNATIONALIS (2006)
Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue
WJ Jabs et al.
KIDNEY INTERNATIONAL (2005)
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy -: A multicenter European study
L Cindolo et al.
CANCER (2005)
Prognostic factors in advanced cancer patients:: Evidence-based clinical recommendations -: A study by the Steering Committee of the European Association for Palliative Care
M Maltoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer
S Lehrer et al.
BJU INTERNATIONAL (2005)
The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder
M Hilmy et al.
BRITISH JOURNAL OF CANCER (2005)
C-reactive protein: A biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy
A Casamassima et al.
JOURNAL OF UROLOGY (2005)
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
SD Fosså et al.
BRITISH JOURNAL OF CANCER (2004)
Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis
MMJ Nielen et al.
ARTHRITIS AND RHEUMATISM (2004)
C-reactive protein: Risk marker or mediator in atherothrombosis?
I Jialal et al.
HYPERTENSION (2004)
C-reactive protein
S Black et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
E Bromwich et al.
BRITISH JOURNAL OF CANCER (2004)
Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter
A Agrawal et al.
MOLECULAR IMMUNOLOGY (2003)
Cardiovascular disease as a long-term complication of treatment for testicular cancer
RA Huddart et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Metastatic renal carcinoma comprehensive prognostic system
J Atzpodien et al.
BRITISH JOURNAL OF CANCER (2003)
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score
I Frank et al.
JOURNAL OF UROLOGY (2002)
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Human C-reactive protein: expression, structure, and function
JE Volanakis
MOLECULAR IMMUNOLOGY (2001)
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer
MT Meinardi et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
